https://www.selleckchem.com/pr....oducts/deruxtecan.ht
endicitis. Further prospective investigation into the role of such patient-driven protocols to mitigate healthcare disparities is warranted. Therapeutic study; Level 3. Therapeutic study; Level 3. Enormous variability in management and cost occurs in CDH care. The purpose of this study was to identify regional mortality and cost patterns underlying this variability. This is a retrospective study of neonatal CDH patients at U.S. hospitals using data from the Pediatric Health Information System (PHIS) database (2015-2018). Patients wer
Like
Comment
Share
